[文献资料]参 考 文 献

Final results of enable 1 ， a phase 3 ， multicenter study of eltrombopag as an adjunct for antiviral treatment of hepatitis C virus-related chronic liver disease associated with thrombocytopenia .Maintenance therapy with peginterferon alfa-2b does not pre ......